KOSDAQ · 225430 · Chemicals · ₩225430

Kmpharmaceutical케이엠제약

225430 · KOSDAQ · ₩225430 · 케이엠제약

₩698 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

[Amended] Report on Results of Acquisition of Treasury Stock[기재정정]자기주식취득결과보고서
Predicted impact: Low
Oct 23, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
Trading halt주권매매거래정지기간변경 (투자자 보호)Oct 2, 2026Open on DART
Other management matters기타경영사항(자율공시) (상장폐지결정 효력정지 가처분 인용 결정)Oct 2, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Sep 16, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 16, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 16, 2026Open on DART
Other management matters기타경영사항(자율공시) (상장폐지결정 등 효력정지 가처분 신청)Sep 15, 2026Open on DART
Trading halt주권매매거래정지기간변경 (투자자 보호)Sep 15, 2026Open on DART
Other Market Notice (Regarding Postponement of Clearance Sale)기타시장안내 (정리매매 보류 관련)Sep 15, 2026Open on DART
Delisting주권매매거래정지 (상장폐지 사유발생)Sep 14, 2026Open on DART
Delisting기타시장안내 (시가총액 미달에 따른 상장폐지 우려 관련 안내)Sep 7, 2026Open on DART
Delisting기타시장안내 (시가총액 미달에 따른 상장폐지 우려 관련 안내)Aug 31, 2026Open on DART
Report on Treasury Stock Acquisition Results자기주식취득결과보고서Aug 28, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Jul 30, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 30, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 30, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 30, 2026Open on DART
Share buyback decision주요사항보고서(자기주식취득결정)Jul 27, 2026Open on DART
Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment Rights Offering)증권발행결과(자율공시) (제3자배정 유상증자)Jul 24, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 20, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 20, 2026Open on DART
Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jul 14, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 8, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 8, 2026Open on DART
Other Market Notice (Potential Designation as Administrative Issue – Market Capitalization Below ₩20B)기타시장안내(관리종목지정우려종목) (시가총액 200억원 미달)Jul 1, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 1, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
Results of Extraordinary Shareholders' Meeting임시주주총회결과Jun 23, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jun 22, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 22, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jun 11, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Jun 5, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)May 29, 2026Open on DART
Trading halt주권매매거래정지해제 (액면병합 주권 변경상장)May 18, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
[Amended] Decision on Share Consolidation[기재정정]주식병합결정May 8, 2026Open on DART
[Amended] Decision on Share Consolidation[기재정정]주식병합결정May 7, 2026Open on DART
Shareholders' meeting called주주총회소집결의 (임시주주총회)May 6, 2026Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 6, 2026Open on DART
[Attached Correction] Decision on Share Consolidation[첨부정정]주식병합결정May 4, 2026Open on DART
[Amended] Decision on Share Consolidation[기재정정]주식병합결정May 4, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Apr 21, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 21, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Kmpharmaceutical / 케이엠제약 / 225430 / KRX:225430

Source: KRX statistical information